NT‐proBNP as a Predictor of Atrial Fibrillation Recurrence After Cryoballoon, Radiofrequency and Pulsed‐Field Ablation
Pacing and Clinical Electrophysiology · 2026-09 · 49 (9) · 1364-1373
DOI: 10.1111/pace.70237 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2026-04-03. Written by Johannes Bruss and 11 co-authors. Institution: Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Major MEDLINE topics: Atrial Fibrillation, Natriuretic Peptide, Brain, Cryosurgery, Peptide Fragments. Cited 1 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Introduction
Natriuretic peptides have shown to predict atrial fibrillation (AF) ablation success using thermal energies. Pulsed‐field ablation (PFA) is a novel AF ablation technology. This study investigates the predictive value of NT‐proBNP and clinical parameters for pulmonary vein isolation (PVI) success using PFA, cryoballoon ablation (CBA), and radiofrequency ablation (RFA).
Methods
We included all patients undergoing primary PVI between May 2019 and December 2023 from our prospective registry, excluding those in randomized trials or without NT‐proBNP measured ≤1 day before the procedure. Follow‐up included 7‐day Holter‐ECGs at 3, 6, and 12 months. The primary endpoint was atrial arrhythmia recurrence between days 90–365. NT‐proBNP was dichotomized using the age‐ and sex‐adjusted 95th percentile in healthy adults.
Results
Among 1,391 patients (median age 67 years; 29% female) undergoing primary PVI with RFA ( n = 302), CBA ( n = 399), or PFA ( n = 690), elevated NT‐proBNP levels were observed in 55%, with no significant differences between ablation modalities. NT‐proBNP correlated with age and left atrial volume and was higher in patients with persistent AF. Overall, 1‐year arrhythmia recurrence rate was 32.1%, without differences between ablation technologies. Elevated NT‐proBNP was associated with recurrence across all subgroups. In multivariate Cox regression, NT‐proBNP and persistent AF were the strongest independent predictors of recurrence. A simplified model including only NT‐proBNP and AF type yielded a concordance index of 0.62.
Conclusions
NT‐proBNP is a robust predictor of atrial arrhythmia recurrence after PVI, independent of the ablation technology, and may support shared, evidence‐based decision‐making with patients regarding ablation success probability.
Trial registration
The Swiss‐AF‐PVI registry is registered with ClinicalTrials.gov (NCT03718364)
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
ORCID profiles: Johannes Bruss, Thomas Kueffer, Fabian Noti, Andreas Haeberlin, Nikola Asenov Kozhuharov, Boldizsar Kovacs, Valon Spahiu, Claudia Herrera Siklody, Tobias Reichlin, Laurent Roten
Cite
APA
Bruss, J., Kueffer, T., Tanner, H., Noti, F., Haeberlin, A., Thalmann, G., Kozhuharov, N. A., Kovacs, B., Spahiu, V., Siklody, C. H., Reichlin, T., & Roten, L. (2026). NT‐proBNP as a Predictor of Atrial Fibrillation Recurrence After Cryoballoon, Radiofrequency and Pulsed‐Field Ablation. Pacing and Clinical Electrophysiology, 49(9), 1364-1373. https://doi.org/10.1111/pace.70237
Vancouver
Bruss J, Kueffer T, Tanner H, Noti F, Haeberlin A, Thalmann G, et al. NT‐proBNP as a Predictor of Atrial Fibrillation Recurrence After Cryoballoon, Radiofrequency and Pulsed‐Field Ablation. Pacing and Clinical Electrophysiology. 2026;49(9):1364-1373. doi:10.1111/pace.70237
BibTeX
@article{Bruss2026,
author = {Bruss, Johannes and Kueffer, Thomas and Tanner, Hildegard and Noti, Fabian and Haeberlin, Andreas and Thalmann, Gregor and Kozhuharov, Nikola Asenov and Kovacs, Boldizsar and Spahiu, Valon and Siklody, Claudia Herrera and Reichlin, Tobias and Roten, Laurent},
title = {NT‐proBNP as a Predictor of Atrial Fibrillation Recurrence After Cryoballoon, Radiofrequency and Pulsed‐Field Ablation},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
volume = {49},
number = {9},
pages = {1364--1373},
doi = {10.1111/pace.70237}
}
EUVIMED